Cencora Raises Fiscal 2026 Adjusted Diluted EPS Outlook to at Least $17.90
Bitget2026/10/21 11:33- Cencora now expects fiscal 2026 adjusted diluted EPS of at least $17.90, versus its previous $17.75-$17.95 range.
- The revised outlook reflects strength in its U.S. Healthcare Solutions segment.
- Its planned American Oncology Network acquisition carries a $2.4 billion enterprise value, including up to $100 million in contingent value rights.
- The acquisition is expected to lift adjusted diluted EPS in the second year following closing.
- Fiscal 2027 expectations will be discussed on the fiscal fourth-quarter 2026 earnings call on November 4, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bloomberg Economists: Anthropic's IPO May Signal the End of the AI Boom
Bloomberg economist Anna Wong believes that Anthropic's actual price per million tokens has dropped significantly since September. Although token usage has surged, its market share has actually declined, indicating that its technological edge has not translated into lasting pricing power. An IPO would bring the pricing and profit margins of cutting-edge AI into the public market for quarterly scrutiny; if its pricing power is weaker than what is implied by its valuation, the AI sector might see an accelerated correction in valuations.
Cosan Publishes Q3 2026 Earnings Call Transcript